ACT, THRX Hit All-time High, NSPH Makes A Big Move, BTX Gets Funding
5/13/2013 10:08:00 PM - RTT News
Merrimack Pharmaceuticals Q1 Net Loss Widens
5/13/2013 11:43:00 AM - RTT News
Predicting Biotech Stock Moves Using Top Consensus Picks By Legendary Fund Managers
5/5/2013 1:23:00 PM - Seeking Alpha
ACOR Leaps, BSX Begins SAMURAI, GTXI, MACK On Watch, SRPT To Meet With FDA In Q3
4/15/2013 9:56:00 PM - RTT News
ARIA's Agenda, New Faces At CBLI, PCYC Scores Hat-trick, NVIV To Uplist
4/8/2013 11:02:00 PM - RTT News
Merrimack: MM-121 Restores Sensitivity To Anti-Estrogen Therapy
4/8/2013 8:17:00 AM - RTT News
Merrimack Says One Cohort Of Phase 2 NSCLC Study Did Not Meet Primary Endpoint
4/4/2013 8:50:00 AM - RTT News
Merrimack's MM-121 Misses Endpoint in Non-Small Cell Lung Cancer Study
4/4/2013 8:45:00 AM - Dow Jones Business News
Cramer's Mad Money - Which Company Should Buy Netflix? (4/3/13)
4/4/2013 7:00:00 AM - Seeking Alpha
Buy Hercules Tech Growth Capital Instead Of OCZ Tech
3/27/2013 6:35:00 AM - Seeking Alpha
Sanofi/MACK Candidate Progresses - Analyst Blog
3/20/2013 4:29:05 PM - Zacks.com
AFFY Mauled, BDSI On Track, GALE Blows, AVXL, INO, MACK On Watch
3/19/2013 12:22:00 AM - RTT News
Merrimack Pharma Q4 12 Earnings Conference Call At 10:00 AM ET
3/14/2013 9:01:00 AM - RTT News
Merrimack Pharmaceuticals Q4 Loss Widens - Quick Facts
3/14/2013 8:47:00 AM - RTT News
Why These 4 Biotechs Could Be Next In Line To See Their Share Prices Rise
3/8/2013 8:09:00 AM - Seeking Alpha
Merrimack To Present At Cowen & Co. Conference; Webcast At 8:00 AM ET
3/6/2013 7:00:00 AM - RTT News
Cramer's Lightning Round - Wait For Cabela's To Explode (12/7/12)
12/9/2012 4:53:00 AM - Seeking Alpha
4 Biotechs With Poor Balance Sheets
12/6/2012 8:07:00 AM - Seeking Alpha
After Hours Most Active for Nov 16, 2012 : SFD, QQQ, WIN, TSN, MSFT, TSS, BAC, MYL, ZGNX, WM, MACK, MMC
11/16/2012 5:44:53 PM - NASDAQ.com News
5 Low-Debt Biotech Stocks Forecasted For Growth
9/22/2012 9:09:00 AM - Seeking Alpha
Street research for Merrimack Pharmaceuticals expected on May 8
5/3/2012 7:00:05 AM - Renaissance Capital
IPO Mania Returns - Real Time Insight
3/29/2012 4:58:01 PM - Zacks.com
Merrimack prices IPO at $7, raising $100 million in proceeds
3/28/2012 5:52:20 PM - Renaissance Capital
Merrimack Pharmaceuticals sets new terms, now seeking $100 million
3/26/2012 9:14:16 AM - Renaissance Capital
10 US IPOs planned for the week of Mar 26
3/26/2012 8:00:02 AM - Renaissance Capital
